FDA.reportPublic FDA data

Livalo 4 MG (as pitavastatin calcium 4.18 MG) Oral Tablet

RxCUI
861654
RxNorm name
Livalo 4 MG (as pitavastatin calcium 4.18 MG) Oral Tablet
Display name
Livalo 4 MG (as pitavastatin calcium 4.18 MG) Oral Tablet
Full name
Livalo 4 MG (as pitavastatin calcium 4.18 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LivaloPITAVASTATIN CALCIUMKowa Pharmaceuticals America, Inc.44dcbf97-99ec-427c-ba50-207e0069d6d22026-03-31Warnings, Adverse reactionsExact identifier
rxcui: 861654

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
44dcbf97-99ec-427c-ba50-207e0069d6d2Livalo 4 MG Oral Tablet [PSN] · pitavastatin calcium 4 MG Oral Tablet [Livalo] [SBD] · Livalo 4 MG (as pitavastatin calcium 4.18 MG) Oral Tablet [SY] · Livalo 4 MG Oral Tablet [SY]411These highlights do not include all the information needed to use LIVALO ® safely and effectively. See full prescribing information for LIVALO. LIVALO (pitavastatin) tablets, for oral use Initial U.S. Approval: 200920260209